Evaluation of silicon dioxide-based coating enriched with bioactive peptides mapped on human vitronectin and fibronectin: in vitro and in vivo assays.
A wide range of biochemical signals promoting cell functions (adhesion, migration, proliferation, and differentiation) and thereby improving the osseointegration process are currently investigated. Unfortunately, their application for the production of bioactive implantable devices is often hampered by their insolubility; instability; and limited availability of a large amount of inexpensive, high-purity samples. An attractive alternative is the use of short peptides carrying the minimum active sequence of the natural factors. Synthetic peptides mapped on fibronectin and vitronectin have been demonstrated to enhance cell adhesion both to polystyrene and acellular bone matrix; in particular, a nonapeptide sequence from human vitronectin works via an osteoblast-specific adhesion mechanism. In this study, we incorporated these peptides into a sol-gel silica dressing applied to coat sand-blasted and acid-attacked titanium samples; measured the kinetic of peptide release; and used titanium disks, coated with a peptide-enriched film, as substrates to determine the peptide concentration that maximizes cell adhesion in vitro. We also evaluated in vivo the capacity of the vitronectin-derived peptide to improve osteogenic activity: histologic analysis revealed markedly improved osteogenic activity around peptide-enriched samples. This article also discusses the role of surface characteristics and the importance of bioactive peptides.
Dettin
Monica
M
Department of Chemical Process Engineering, University of Padova, Padova, Italy.
Bagno
Andrea
A
Morpurgo
Margherita
M
Cacchioli
Antonio
A
Conconi
Maria Teresa
MT
Di Bello
Carlo
C
Gabbi
Carlo
C
Gambaretto
Roberta
R
Parnigotto
Pier Paolo
PP
Pizzinato
Sara
S
Ravanetti
Francesca
F
Guglielmi
Massimo
M
D000818:Animals; D002478:Cells, Cultured; D020099:Coated Materials, Biocompatible / Q000008:administration & dosage; D004353:Drug Evaluation, Preclinical; D005353:Fibronectins / Q000008:administration & dosage / Q000378:metabolism* / Q000648:ultrastructure; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage / Q000138:chemical synthesis / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D012822:Silicon Dioxide / Q000008:administration & dosage; D013499:Surface Properties; D019096:Vitronectin / Q000008:administration & dosage / Q000378:metabolism* / Q000648:ultrastructure
D020099:Coated Materials, Biocompatible; D005353:Fibronectins; D010446:Peptide Fragments; D019096:Vitronectin; D012822:Silicon Dioxide